Literature DB >> 27703515

Screening and identification of microRNA involved in unstable angina using gene-chip analysis.

Si Li1, Ya-Nan Sun2, Yun-Tao Zhou2, Chun-Lai Zhang2, Feng Lu2, Jia Liu2, Xiao-Ming Shang1.   

Abstract

Increasing evidence has suggested that microRNA (miRNA) may play a role in the pathogenesis of cardiovascular disease, which has led to a greater understanding of the complex pathophysiological processes underlying unstable angina (UA). The present study aimed to investigate changes in the miRNA expression profiles of patients with UA using gene-chip analysis, in order to further elucidate the pathogenesis of UA. Total RNA was extracted and purified from plasma samples collected from patients with UA and healthy controls. The samples underwent microarray analysis using an Exiqon miRCURY LNA™ microRNA Array. Differentially expressed miRNAs were identified by volcano plot filtering, and were validated using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). In addition, functional annotation of the differentially expressed miRNAs involved gene ontology analyses. Among the 212 miRNAs differentially expressed between the two groups, 82 were upregulated and 130 were downregulated. Notably, the results of the RT-qPCR were consistent with the gene-chip results. The miRNAs identified in the present study may be potential novel biomarkers for the prevention and early diagnosis of UA. Furthermore, the results of the present study suggested that UA occurs as a result of complex and dynamic processes regulated by numerous factors, including multiple miRNAs.

Entities:  

Keywords:  gene chip; microRNA; reverse transcription-quantitative polymerase chain reaction; unstable angina

Year:  2016        PMID: 27703515      PMCID: PMC5038914          DOI: 10.3892/etm.2016.3646

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  38 in total

Review 1.  Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE): updated standing orders for ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction.

Authors:  Christopher P Cannon
Journal:  Crit Pathw Cardiol       Date:  2010-06

Review 2.  Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

Authors:  Esther E Creemers; Anke J Tijsen; Yigal M Pinto
Journal:  Circ Res       Date:  2012-02-03       Impact factor: 17.367

Review 3.  Chromosomal Microarray Analysis (CMA) a Clinical Diagnostic Tool in the Prenatal and Postnatal Settings.

Authors:  Nurit Assia Batzir; Mordechai Shohat; Idit Maya
Journal:  Pediatr Endocrinol Rev       Date:  2015-09

Review 4.  Unstable angina and non-ST elevation myocardial infarction.

Authors:  Eugene Braunwald
Journal:  Am J Respir Crit Care Med       Date:  2011-12-28       Impact factor: 21.405

5.  MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A.

Authors:  Carmen Urbich; David Kaluza; Timo Frömel; Andrea Knau; Katrin Bennewitz; Reinier A Boon; Angelika Bonauer; Carmen Doebele; Jes-Niels Boeckel; Eduard Hergenreider; Andreas M Zeiher; Jens Kroll; Ingrid Fleming; Stefanie Dimmeler
Journal:  Blood       Date:  2011-12-19       Impact factor: 22.113

6.  MiR-33 contributes to the regulation of cholesterol homeostasis.

Authors:  Katey J Rayner; Yajaira Suárez; Alberto Dávalos; Saj Parathath; Michael L Fitzgerald; Norimasa Tamehiro; Edward A Fisher; Kathryn J Moore; Carlos Fernández-Hernando
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

7.  MicroRNA-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor.

Authors:  Sufang Li; Jingyi Ren; Ning Xu; Jing Zhang; Qiang Geng; Chengfu Cao; Chongyou Lee; Junxian Song; Jingjin Li; Hong Chen
Journal:  J Mol Cell Cardiol       Date:  2014-07-03       Impact factor: 5.000

Review 8.  Circulating microRNAs and hypertension--from new insights into blood pressure regulation to biomarkers of cardiovascular risk.

Authors:  Simon P R Romaine; Fadi J Charchar; Nilesh J Samani; Maciej Tomaszewski
Journal:  Curr Opin Pharmacol       Date:  2016-01-28       Impact factor: 5.547

9.  MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure.

Authors:  Geert C van Almen; Wouter Verhesen; Rick E W van Leeuwen; Mathijs van de Vrie; Casper Eurlings; Mark W M Schellings; Melissa Swinnen; Jack P M Cleutjens; Marc A M J van Zandvoort; Stephane Heymans; Blanche Schroen
Journal:  Aging Cell       Date:  2011-05-25       Impact factor: 9.304

Review 10.  Impact of miRNAs on cardiovascular aging.

Authors:  Seahyoung Lee; Eunhyun Choi; Min-Ji Cha; Ae-Jun Park; Cheesoon Yoon; Ki-Chul Hwang
Journal:  J Geriatr Cardiol       Date:  2015-09       Impact factor: 3.327

View more
  4 in total

1.  Evaluation of Oxidative Stress, Apoptosis, and Expression of MicroRNA-208a and MicroRNA-1 in Cardiovascular Patients.

Authors:  Asma Mohammadi; Ali Reza Balizadeh Karami; Vahid Dehghan Mashtani; Tooba Sahraei; Zeinab Bandani Tarashoki; Ehsan Khattavian; Sara Mobarak; Hossein Moradi Kazerouni; Esmat Radmanesh
Journal:  Rep Biochem Mol Biol       Date:  2021-07

2.  Circulating microRNAs as potential biomarkers for coronary plaque rupture.

Authors:  Sufang Li; Chongyou Lee; Junxian Song; Changlin Lu; Jun Liu; Yuxia Cui; Huizhu Liang; Chengfu Cao; Feng Zhang; Hong Chen
Journal:  Oncotarget       Date:  2017-07-18

3.  Screening of key genes associated with R‑CHOP immunochemotherapy and construction of a prognostic risk model in diffuse large B‑cell lymphoma.

Authors:  Ran Liu; Zhi Chen; Shujun Wang; Gang Zhao; Yan Gu; Qi Han; Baoan Chen
Journal:  Mol Med Rep       Date:  2019-08-29       Impact factor: 2.952

Review 4.  Genomic Variants and Multilevel Regulation of ABCA1, ABCG1, and SCARB1 Expression in Atherogenesis.

Authors:  Alexandra V Rozhkova; Veronika G Dmitrieva; Elena V Nosova; Alexander D Dergunov; Svetlana A Limborska; Liudmila V Dergunova
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.